Actual enrollment increased by 42 participants
Before: 178 participants (actual). After: 220 participants (actual).
Study sponsor: Iovance Biotherapeutics, Inc. · IOVA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 178 participants (actual). After: 220 participants (actual).